Total pharmaceutical sales numbers in North America are projected to amount to around 853 billion U.S. dollars in 2028, making it the regional submarket with the highest global pharma sales. Pharmaceutical spending and product revenue In 2026, the United States is projected to spend between 685 and 715 billion U.S. dollars on medicine, making it the country with the highest pharmaceutical spending by far. China, which is estimated to be in second place, has a maximum projected expenditure estimate of 190 billion U.S. dollars for that year. The top pharmaceutical product for 2026 is expected to be Keytruda. Keytruda by Merck & Co is forecast to generate almost 27 billion U.S. dollars in revenue in 2026. Chemical and biological substances Given that U.S. pharmaceutical R&D expenditures are the highest in the world, it comes to no surprise that the United States produces the largest volume of new chemical or biological entities each year. Between 2019 and 2023, American companies introduced a total of 148 new chemical or biological substances. Within the same period, Europe introduced 81 new entities.

In 2028, U.S.-based pharmaceutical company AbbVie is expected to generate nearly 66 billion U.S. dollars in sales revenue through prescription drugs, making it the world's top drug manufacturer. This statistic illustrates the sales forecast of the leading 10 pharmaceutical companies worldwide in 2028.

Forecast: Total Pharmaceutical Sales in Italy 2023 - 2027 Discover more data with ReportLinker!

In 2023, Mexico sold around 10.83 billion U.S. dollars worth of pharmaceutical products. This shows an increase in comparison to the previous year, when the North American country's pharma sales value added up to 10.12 billion dollars. In 2020, pharmaceutical sales in Mexico were estimated at around 11.1 billion U.S. dollars. In 2021, the pharmaceutical industry in Mexico employed over 52,000 people.

Forecast: Total Pharmaceutical Sales in Germany 2023 - 2027 Discover more data with ReportLinker!

Forecast: Total Pharmaceutical Sales in the Netherlands 2023 - 2027 Discover more data with ReportLinker!

As of June 2023, it was forecasted that in 2027 global sales for the leading three pharmaceutical cannabis products will stand at nearly 1.4 billion U.S. dollars. The three major products are Epidiolex, Dronabinol, and Sativex. This statistic illustrates the estimated sales forecast of major cannabis pharmaceutical products worldwide from 2023 to 2027.

Forecast: Total Pharmaceutical Sales in Denmark 2023 - 2027 Discover more data with ReportLinker!

All types of drugs are expected to be affected to lesser or greater degrees by the COVID-19 outbreak in South Korea in 2020. Antiviral and respiratory drugs, along with those used for treating life-threatening conditions are expected to be the least affected. In contrast, drugs for non-urgent illnesses and conditions are expected to be most affected, as people stay away from hospitals if possible.

The size and share of the market is categorized based on Type (Antibiotics, Antiparasitics, Vaccines, Anti-inflammatory Drugs, Growth Promoters) and Application (Livestock, Companion Animals, Poultry, Swine, Aquaculture, Equine) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

Forecast: Total Pharmaceutical Sales in Italy 2022 - 2026 Discover more data with ReportLinker!

Over the forecast period until 2029, the online revenue share is forecast to exhibit fluctuations among the two segments. Comparing the two different segments for the year 2029, the segment 'Offline' leads the ranking with 83.57 percent. Contrastingly, 'Online' is ranked last, with 16.43 percent. Their difference, compared to Offline, lies at 67.14 percentage points. Find further statistics on other topics such as a comparison of the online revenue share in Malaysia and a comparison of the online revenue share in Singapore. The Statista Market Insights cover a broad range of additional markets.

The size and share of the market is categorized based on Application (Dental, Glassware & Equipment, Medical Devices, Others) and Product (Hpq Powder, Crystal Silica, Fumed Silica, Silica Gel, Other) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

It is projected that Pfizer will again be the leading company based on pharmaceutical revenue in 2023, still boosted by high Comirnaty (COVID-19 vaccine) sales. Merck & Co., manufacturer of top drug Keytruda, should increase to second place, according to these projections.

The global pharmaceutical market is expected to grow at a CAGR of 5% during 2011-2017, exceeding sales worth US$ 1.1 Trillion by 2017. This market, however, is expected to undergo a number of transitions which would impact the course of its growth. These transitions include a shift of growth from the developed to the emerging markets, an increasing focus on biopharmaceuticals compared to small molecule drugs and an increasing preference for generics compared to their branded versions. As a result of these transformations; the need for a user friendly, robust and comprehensive pharmaceutical market intelligence has become imperative for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the pharmaceutical market in some form or the other.

IMARC Group, one of the world’s leading research and advisory firms, introduces a new and revolutionary way to understand and evaluate the global pharmaceutical market with its Microsoft Excel based report entitled “Global Pharmaceutical Market Report & Forecast: 2012-2017”. This report provides an analytical and statistical insight into the global pharmaceutical market. The study, which has been undertaken using desk based as well as primary market research has analyzed the following aspects of the global pharmaceutical market.

What We Have Achieved in This Report?

Regions Covered: Global, North America, Europe, Asia Pacific, Latin America & Caribbean and Middle East & Africa

Countries Covered in Each Region

North America: United States and Canada

Europe: Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Netherlands, Poland, Greece, Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania, Denmark, Czech Republic, Finland, Ireland, Norway, Slovakia, Bulgaria, Croatia, Slovenia, Lithuania, Latvia, Luxembourg and Estonia

Asia Pacific: Japan, China, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and Singapore

Latin America & Caribbean:Brazil, Mexico, Venezuela, Argentina, Puerto Rico, Colombia, Chile, Ecuador, Peru, Dominican Republic and Uruguay

Middle East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco, United Arab Emirates Lebanon, Tunisia, Jordan and Kuwait

Focus of the Analysis:

• Historical sales performance (2007-2011) for each country
• Historical sales performance (2007-2011) for each region
• Sales forecast (2012-2017) for each country
• Sales forecast (2012-2017) for each region
• Sales performance of key manufacturers for each country (2007-2011)
• Sales performance of key therapeutic areas for each country (2007-2011)
• Country wise sales breakup for each region (2007-2011)
• Country wise sales breakup forecast for each region (2012-2017)

Key Questions Answered;

• What was the historical performance of the global pharmaceutical market?
• Which are the key regions and countries in the global pharmaceutical market?
• Which are the largest pharmaceutical markets in the world?
• Which are the fastest growing pharmaceutical markets in the world?
• Which markets are expected to witness the slowest growth in the coming years?
• Which countries represent the key markets for each region?
• What has been the performance of various therapeutic classes in each country?
• Who are the top pharmaceutical manufacturers in each country?
• What are the market shares of the top pharmaceutical manufacturers in each country?

Why You should Buy This Report?

• To gain a comprehensive understanding on the historical, current and future pharmaceutical market trends across 70 countries in 6 regions.
• To identify potential regions, countries, therapeutic areas, partners and competitors for market entry and expansion plans.
• As a tool for developing investment strategies by identifying the biggest winners and losers across various regions and countries.
• To ensure a successful M&A and partnership strategy by identifying therapeutic areas and companies with the most promising outlook.

This statistic shows the projected average peak sales per new pharmaceutical pipeline asset from 2013 to 2023, in million U.S. dollars.The projected average peak sales per new asset dropped from 555 million U.S. dollars in 2017 to 362 million U.S. dollars in 2023.

The revenue in the pharmaceuticals market in Italy was forecast to continuously increase between 2024 and 2029 by in total 3.4 billion euro (+21.41 percent). After the seventh consecutive increasing year, the indicator is estimated to reach 19.32 billion euro and therefore a new peak in 2029. Find further information concerning the revenue change in the pharmaceuticals market in Italy and the revenue change in the 'Anti-Diabetes Drugs' segment of the pharmaceuticals market in Italy. The Statista Market Insights cover a broad range of additional markets.

Snapshot img

US Pharmacy Market Size 2024-2028

The US pharmacy market size is forecast to increase by USD 90.8 billion at a CAGR of 3.14% between 2023 and 2028. In the dynamic market, several drivers, trends, and challenges shape the industry landscape. The aging population in the United States is a significant growth factor, leading to an increase in pharmaceutical sales. Pharmaceutical exports, biotechnology, biosimilars, biologics, antiretroviral drugs, and vaccines are significant contributors to the sector's growth. This demographic shift also necessitates the adoption of telepharmacy services to cater to the healthcare needs of an expanding elderly population. Another trend in the market is the digitization of electronic health records (EHRs). Additionally, rising pricing in pharmaceuticals and reimbursement pressures are predefined factors influencing market growth. Quality control and licensing are essential aspects of the market, with industry associations playing a crucial role in setting standards and ensuring regulatory compliance. According to recent survey results, retail stores and hospitals remain the key distribution channels for pharmaceuticals.

Request Free Sample

The market encompasses a wide range of healthcare products, including prescription medications, over-the-counter drugs, and health supplements. Pharmacists play a crucial role in ensuring the safe and effective use of these products by patients. With the increasing adoption of technology in healthcare, digital solutions have become essential components of modern pharmacy services. The growth of retail and hospital pharmacies is significantly influenced by the demand for OTC medications and generic medicines, with projections tied to GDP performance, especially during the April-January period when items like hydroxychloroquine became prominent in the market for medical goods. One significant trend in the market is the integration of technology into various aspects of pharmacy operations.

Furthermore, these digital pharmacies offer convenience and accessibility, allowing patients to order their prescriptions and over-the-counter medications from the comfort of their homes. National health services are increasingly adopting EHRs to improve patient care and streamline operations. EHRs enable pharmacists to access patients' medical histories, allergies, and medication lists, ensuring accurate and safe prescription dispensing. Technology is also transforming the production and distribution of healthcare products. API producers are leveraging digital solutions to improve the efficiency and quality of their manufacturing processes. The use of technology in the market is expected to continue growing, driven by the need for improved patient care, increased convenience, and cost savings.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Prescription
  OTC


Ownership

  Pharmacy chain
  Independent


Type

  Retail pharmacy
  Hospital pharmacy
  Others


Geography

  US

By Product Insights

The Prescription segment is estimated to witness significant growth during the forecast period. Pharmaceutical businesses in the United States have leveraged the power of market segmentation to better understand consumer needs and preferences in the prescription sector. This approach allows companies to develop targeted marketing strategies, optimize inventory, and enhance overall customer satisfaction. One crucial aspect of prescription-based market segmentation involves categorizing customers based on their therapeutic requirements. These categories span various health conditions, including cardiovascular health, mental health, respiratory diseases, chronic pain management, and numerous others.

Furthermore, by segmenting the market, pharmacies ensure a comprehensive range of prescription medications for each category, enabling them to offer customized treatment solutions to their clients. The Internet's increasing penetration in the US has significantly influenced market segmentation in the pharmaceutical industry. The S-curve method, a popular analytical tool, helps visualize the growth patterns of various market segments. Exchange rates and representativeness are essential factors to consider when analyzing data from Global GCS data, a valuable resource, that provides insights into consumer behavior and trends within these segments. By staying abreast of market trends and consumer preferences, pharmacies can cater to the unique needs of their clientele, ultimately driving customer loyalty and business success.

Get a glance at the market share of various segments Request Free Sample

The prescription segment was valued at USD 425.20 billion in 2018 and showed a gr

Forecast: Total Pharmaceutical Sales in Norway 2023 - 2027 Discover more data with ReportLinker!

The market size of the Aseptic Packaging For Pharmaceutical Sales Market is categorized based on Type (Bottles, Ampoules, Vials, Prefilled Syringes, Bags & Pouches, Others;) and Application (Vaccines, Antibiotics, Biotech Products, Others;) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

This report provides insights into the market size and forecasts the value of the market, expressed in USD million, across these defined segments.